Quantitative Total Extensible Imaging (QTxI) vs Viz CTP

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Viz.ai

AI Verdict

Tool A is designed for quantitative analysis and monitoring of medical images, primarily for oncology treatment assessment, focusing on detailed ROI evaluation. Tool B specializes in AI-powered disease detection and intelligent care coordination for acute conditions, utilizing a broad range of algorithms to streamline diagnosis and treatment workflows. While both leverage AI for medical image analysis, their distinct primary applications and target clinical workflows make them suitable for different needs.

Choose Quantitative Total Extensible Imaging (QTxI) if…

Choose Quantitative Total Extensible Imaging (QTxI) if your primary need is comprehensive, quantitative analysis and long-term monitoring of disease progression and treatment response, especially in oncology. This tool is ideal for identifying, contouring, and statistically analyzing Regions of Interest across multiple modalities (CT and PET) to track subtle changes over time and generate detailed reports.

View Quantitative Total Extensible Imaging (QTxI) →

Choose Viz CTP if…

Choose Viz CTP if your priority is rapid, AI-powered detection of acute conditions and intelligent care coordination to streamline time-sensitive clinical workflows. This platform excels at leveraging numerous FDA-cleared algorithms for real-time image analysis (e.g., stroke detection) and provides mobile access with integrated communication tools to accelerate diagnosis and treatment for critical cases.

View Viz CTP →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Quantitative Total Extensible Imaging (QTxI) Viz CTP
Pricing Contact for pricing Subscription model
Deployment Cloud-based Cloud-native solution, integrates with PACS and EHRs.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz CTP

Viz CTP emphasizes real-time mobile access, intelligent care coordination, and prioritized worklists, suggesting a more streamlined and broadly usable solution for diverse clinical workflows. QTxI, while powerful for quantitative analysis, appears more specialized for in-depth image evaluation within oncology.

Clinical Value

Viz CTP

Viz CTP boasts over 50 FDA-cleared algorithms for AI-powered disease detection and intelligent care coordination across various conditions, offering wider clinical applicability and impact. QTxI is specialized for quantitative analysis in oncology treatment monitoring, demonstrating prognostic value in that specific domain.

Pricing & Value

Viz CTP

Viz CTP offers a more transparent pricing model with a subscription based on the number of algorithms used and the size of the population served. QTxI's pricing is not publicly available and requires contacting the vendor for custom pricing, making value assessment less clear.

Enterprise Readiness

Viz CTP

Both tools are cloud-based, HIPAA-compliant, and FDA-cleared, indicating strong foundational readiness. However, Viz CTP explicitly highlights integration with PACS and EHRs, which is a critical feature for seamless adoption into existing hospital IT infrastructure.

Innovation

Viz CTP

Viz CTP positions itself as a 'pioneer in AI-powered disease detection and intelligent care coordination' with over 50 FDA-cleared algorithms and features like AI-powered motion artifact correction. While QTxI offers significant innovation in quantitative oncology imaging, Viz CTP's broader scope and continuous development across multiple disease areas suggest a wider innovative footprint.

Support & Docs

Viz CTP

Viz CTP provides a comprehensive support infrastructure, including a knowledge base with tips and tutorials, 24/7 urgent phone support, email support, user guides, and a 'Viz Academy' for clinical education. AIQ Solutions' public offerings primarily consist of validation reports, compliance policies, and publications, with less explicit detail on dedicated user support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Quantitative Total Extensible Imaging (QTxI) Viz CTP
Tool Name Quantitative Total Extensible Imaging (QTxI) Viz CTP
Company AIQ Solutions Viz.ai
Tagline Optimizing late-stage cancer care with technology-enabled service. AI-powered disease detection and intelligent care coordination
Primary Focus Quantitative analysis of Regions of Interest for improved treatment monitoring, particularly in oncology. AI-powered disease detection and intelligent care coordination, leveraging over 50 FDA-cleared algorithms to analyze medical imaging and streamline clinical workflows for faster diagnosis and treatment.
Key Features (Imaging Modalities) Evaluation and information management of digital medical images (DICOM CT and PET); Display, registration, and fusion of medical images from multiple modalities Real-time, mobile access to high-fidelity imaging (DICOM viewer, 3D manipulation); Automated image analysis and interpretation (e.g., CT perfusion maps, LVO detection)
Specialties Nuclear Medicine, Oncology, Radiology Emergency Medicine, Neurology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Quantitative Total Extensible Imaging (QTxI) and Viz CTP.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

QTxI is designed for medical professionals to evaluate and manage digital medical images (DICOM CT and PET), enabling quantitative analysis of Regions of Interest for improved treatment monitoring, particularly in oncology. Viz CTP focuses on AI-powered disease detection and intelligent care coordination, leveraging over 50 FDA-cleared algorithms to analyze medical imaging and streamline clinical workflows for faster diagnosis and treatment, with specific features like CT perfusion maps and LVO detection suggesting a strong neurovascular/stroke application.
QTxI offers automated quantification of Regions of Interest (ROIs) and changes in ROIs (via its QTBI module), focusing on quantitative and statistical analysis of full or partial-body scans. Viz CTP leverages over 50 FDA-cleared AI algorithms for disease detection, automated image analysis and interpretation (e.g., CT perfusion maps, LVO detection), AI-powered motion artifact correction for CTP, and automated measurements like ICH volume and subdural thickness/midline shift.
QTxI specifically supports the evaluation and information management of digital medical images from DICOM CT and PET modalities, including display, registration, and fusion. Viz CTP is primarily focused on analyzing CT perfusion images of the brain, producing parametric color maps and calculating CT perfusion parameters.
QTxI primarily focuses on image evaluation, quantitative analysis, 3D interactive rendering of images with highlighted ROIs, and automated report generation to support treatment monitoring. Viz CTP emphasizes intelligent care coordination and communication through a HIPAA-compliant messaging platform, real-time mobile access to high-fidelity imaging, prioritized worklists, and EHR integration.
QTxI provides quantitative and statistical analysis of full or partial-body scans, focusing on the identification, contouring, and automated quantification of Regions of Interest (ROIs) and changes in ROIs. Viz CTP offers AI-powered disease detection, automated image analysis and interpretation (e.g., CT perfusion maps, LVO detection), and automated measurements such as ICH volume and subdural thickness/midline shift.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.